| Literature DB >> 26086678 |
Jing Li1, Jie Yang1, Yu-wei Lu2, Song Wu1, Ming-rui Wang1, Ji-min Zhu1.
Abstract
As a member of superantigens (SAgs) produced by Staphylococcus aureus, staphylococcal enterotoxin B (SEB) is a exotoxin superantigen that can regulate the activity of immunomodulatory and pro-inflammatory cell types. In addition, SEB plays a critical role in the pathogenesis of autoimmune disorders either by initiating the autoimmune process or by inducing a relapse in an individual in clinical remission from an autoimmune disorder. SEB can directly activate T lymphocytes, leading to the release of cytokines, superoxides, or other mediators of inflammation either directly or indirectly, because of its unique ability to cross-link human major histocompatibility complex (MHC) class II and T cell receptors (TCR), forming a trimolecular complex. This review discusses the potential effects of SEB in the pathogenesis of autoimmune diseases such as multiple sclerosis, systemic lupus erythematosus, and rheumatoid arthritis, and explores some updated therapeutic medications to neutralize SEB.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26086678 DOI: 10.1089/vim.2015.0017
Source DB: PubMed Journal: Viral Immunol ISSN: 0882-8245 Impact factor: 2.257